About US
Contact us
>>Back
Diabetes is Fastest Growing Pharmaceutical Market
- Publisher：
- Publication：2011/8/15
The market for diabetes treatments is the fastest growing in the pharmaceutical sector, and costs related to the prevention and treatment of the disease are expected to grow to $490bn by 2030 according to new research.
Research analysis firm Frost & Sullivan has reported that the global population of adults suffering from diabetes is expected to rapidly increase from the current 285 million people to 438 million, representing 7.8% of the global adult population, by 2030.
Countries with the largest diabetes populations include India, with 50.8 million sufferers and China, with 43.2 million sufferers.
With the rise in diabetes sufferers, new forms of co-therapies, such as glucagon-like peptide agonists and sodium-dependent glucose transporter inhibitors, are expected to witness extended growth and become strong competitors in the future.